APA

Chrysostomakis S. I., Karalis I. K., Simantirakis E. N., Koutsopoulos A. V., Mavrakis H. E., Chlouverakis G. I. & Vardas P. E. (20080205). Angiotensin II type 1 receptor inhibition is associated with reduced tachyarrhythmia-induced ventricular interstitial fibrosis in a goat atrial fibrillation model. : Cardiovascular drugs and therapy.

Chicago

Chrysostomakis Stavros I, Karalis Ioannis K, Simantirakis Emmanuel N, Koutsopoulos Anastasios V, Mavrakis Hercules E, Chlouverakis Gregory I and Vardas Panos E. 20080205. Angiotensin II type 1 receptor inhibition is associated with reduced tachyarrhythmia-induced ventricular interstitial fibrosis in a goat atrial fibrillation model. : Cardiovascular drugs and therapy.

Harvard

Chrysostomakis S. I., Karalis I. K., Simantirakis E. N., Koutsopoulos A. V., Mavrakis H. E., Chlouverakis G. I. and Vardas P. E. (20080205). Angiotensin II type 1 receptor inhibition is associated with reduced tachyarrhythmia-induced ventricular interstitial fibrosis in a goat atrial fibrillation model. : Cardiovascular drugs and therapy.

MLA

Chrysostomakis Stavros I, Karalis Ioannis K, Simantirakis Emmanuel N, Koutsopoulos Anastasios V, Mavrakis Hercules E, Chlouverakis Gregory I and Vardas Panos E. Angiotensin II type 1 receptor inhibition is associated with reduced tachyarrhythmia-induced ventricular interstitial fibrosis in a goat atrial fibrillation model. : Cardiovascular drugs and therapy. 20080205.